Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.
Ventilator-Associated Pneumonia (VAP) is a common complication of mechanical ventilation. Overall, the percentage of VAP or...
Tags: COVID-19
Clinical trials continue to evolve and so do the methodologies used to support and provide the vital clinical trial monitoring...
Tags: Pharm-Olam Insights, CRO Services
Rare disease drug development varies from the pathways seen in more established indications. The sample sizes are often...
Pharm-Olam is committed to following our industry’s best practices – sometimes even those from other segments of our industry....
Tags: Data Management
Systemic lupus erythematosus is an autoimmune disease that presents differently in each person. There are roughly 150 people...
Tags: Pharm-Olam Insights, Autoimmune
The COVID Pandemic is continuing to evolve. Governments and companies around the world are striving to develop vaccines and...
Earlier this year, Pharm-Olam partnered with Informa’s Pharma Intelligence to draft a white paper that discusses the...
Tags: Infectious Disease & Vaccines, COVID-19, Global Coverage
The COVID-19 Pandemic continues to evolve and fluctuate across the globe – but not evenly or predictably. Some countries have...
Tags: Pharm-Olam Insights, Infectious Disease & Vaccines, Investigator Insights,
Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.
